We are live on ! Find out more
DSGN icon

Design Therapeutics
DSGN

60 hedge funds and large institutions have $773M invested in Design Therapeutics in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

480% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 5

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

86% more capital invested

Capital invested by funds: $415M → $773M (+$358M)

15% more funds holding

Funds holding: 52 → 60 (+8)

14.14% more ownership

Funds ownership: 50.85% → 64.98% (+14%)

Holders
60
Holders Change
+8
Holders Change %
+15.38%
% of All Funds
0.92%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
13
Increased
29
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$15.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$13.4M
3
Principal Financial Group
Principal Financial Group
Iowa
+$5.18M
4
EC
EcoR1 Capital
California
+$4.98M
5
ACA
Avoro Capital Advisors
New York
+$2.88M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$11.4M
2
CS
Credit Suisse
Switzerland
-$3.47M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.72M
4
Citadel Advisors
Citadel Advisors
Florida
-$650K
5
OCA
Octagon Capital Advisors
New York
-$219K
Name Holding Trade Value Shares
Change 		Change in
Stake
GTC
26
Ghost Tree Capital
New York
$2.89M +$2.32M +135,000 New
Charles Schwab
27
Charles Schwab
California
$2.54M +$481K +28,035 +31%
Goldman Sachs
28
Goldman Sachs
New York
$1.45M +$218K +12,704 +23%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.44M +$526K +30,632 +84%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$1.41M – – –
TCM
31
Tekla Capital Management
Massachusetts
$1.4M +$1.12M +65,351 New
N
32
Nuveen
North Carolina
$1.32M +$516K +30,068 +70%
Bank of America
33
Bank of America
North Carolina
$1.18M +$400K +23,307 +74%
Ensign Peak Advisors
34
Ensign Peak Advisors
Utah
$1.07M – – –
Citigroup
35
Citigroup
New York
$604K +$58.2K +3,391 +14%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$499K +$218K +12,700 +120%
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
$494K +$396K +23,052 New
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$373K – – –
Deutsche Bank
39
Deutsche Bank
Germany
$364K +$155K +9,003 +112%
JP Morgan Chase
40
JP Morgan Chase
New York
$337K +$130K +7,598 +93%
DekaBank Deutsche Girozentrale
41
DekaBank Deutsche Girozentrale
Germany
$336K +$292K +17,000 New
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$311K +$125K +7,279 +101%
AIG
43
American International Group
New York
$303K +$112K +6,509 +85%
ProShare Advisors
44
ProShare Advisors
Maryland
$291K +$233K +13,596 New
Morgan Stanley
45
Morgan Stanley
New York
$285K +$101K +5,900 +80%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$277K +$20.9K +1,219 +10%
MIM
47
MetLife Investment Management
New Jersey
$233K +$187K +10,864 New
Wells Fargo
48
Wells Fargo
California
$213K +$171K +9,943 New
Invesco
49
Invesco
Georgia
$206K +$165K +9,622 New
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$172K +$138K +8,048 New
1
2
3

DSGN Hedge Fund Activity: Q4 2021 in Review

60 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Design Therapeutics (DSGN) for Q4 2021, worth a combined $773M — up 86% from $415M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new DSGN positions and 5 closed out — a net gain of 8 holders — while 29 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $15.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $11.4M.

  • 60 institutional investors held Design Therapeutics (DSGN) as of Q4 2021, up from 52 in Q3 2021.
  • Funds reported $773M of Design Therapeutics stock for Q4 2021, up 86% quarter-over-quarter.
  • 13 funds opened new Design Therapeutics positions in Q4 2021 and 5 closed out, a net change of +8 holders.
  • The largest Design Therapeutics buyer in Q4 2021 was BlackRock, an estimated $15.5M added.
  • The largest Design Therapeutics seller in Q4 2021 was T. Rowe Price Associates, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.